News

Poster at Connective Tissue Oncology Society in London
18-11-2008

GP Pharm will present a poster in the “14th Annual Meeting of the Connective Tissue Oncology Society”, next November 13-15. This poster will be untitled:
PHASE I-II STUDY OF A NEW FORMULATION OF NON-PEGYLATED LIPOSOMAL DOXORUBICIN (DOXO GP-PHARM) AS FIRST-LINE TREATMENT OF OLDER PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMAS (STS): A GEIS STUDY. And includes resuming conclusions for such study (Abstract ID: 35129 )